Literature DB >> 18784085

The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa.

Subramanian Yegneswaran1, Tilman M Hackeng, Philip E Dawson, John H Griffin.   

Abstract

To test the hypothesis that factor Xa (fXa) interacts with protein S, fXa was labeled active-site specifically with a dansyl (D) dye via a Glu-Gly-Arg (EGR) tether to yield DEGR-fXa(i). When protein S was added to phosphatidylcholine/phosphatidylserine (PC/PS, 4:1) vesicle-bound DEGR-fXa(i), the anisotropy of the dansyl moiety was altered from 0.219 +/- 0.002 to 0.245 +/- 0.003. This change in dansyl anisotropy was not observed when DEGR-Xa(i) was titrated with protein S in the absence of PC/PS vesicles, or in the presence of 100% PC vesicles, or when PC/PS vesicle-bound DEGR-fXa(i) was titrated with thrombin-cleaved protein S. The protein S-dependent dansyl fluorescence change was specific for fXa because it was not observed for two homologous and similarly labeled DEGR-fIXa(i) and DEGR-fVIIa(i). Furthermore, protein S specifically and saturably altered the fluorescence anisotropy of PC/PS-bound active site-labeled LWB-FPR-fXa(i) (Kd = 33 nm) and was photocross-linked to PC/PS-bound LWB-FPR-fXa(i) analog, independently confirming the above results. Chemically synthesized microprotein S, comprising residues 1-116 of protein S and including the gamma-carboxyglutamic-rich domain, the thrombin-sensitive region (TSR), and the first epidermal growth factor-like domain (EGF1) of protein S, altered the anisotropy of PC/PS-bound DEGR-fXa(i) from 0.219 to 0.242, similar to the effect of the protein S titration (Kd = 303 nm), suggesting that microprotein S binds to DEGR-fXa(i). To identify individual protein S domain(s) that binds DEGR-fXa(i), the EGF1 and TSR domains were chemically synthesized and studied. The TSR altered the anisotropy of DEGR-fXa(i) by approximately 16% (Kd = 3.9 microm), but the EGF1 domain had no effect on the signal. In controls, the TSR domain did not alter the anisotropy of DEGR-fIXa(i) and DEGR-fVIIa(i), respectively. These data demonstrate that membrane-bound fXa binding to protein S involves the TSR of protein S.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784085      PMCID: PMC2586267          DOI: 10.1074/jbc.M806527200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Plasma contains protein S monomers and multimers with similar direct anticoagulant activity.

Authors:  M J Heeb; K-P Radtke; J A Fernández; L Tonnu
Journal:  J Thromb Haemost       Date:  2006-07-05       Impact factor: 5.824

3.  EGF-like module pair 3-4 in vitamin K-dependent protein S: modulation of calcium affinity of module 4 by module 3, and interaction with factor X.

Authors:  Y Stenberg; A Muranyi; C Steen; E Thulin; T Drakenberg; J Stenflo
Journal:  J Mol Biol       Date:  1999-10-29       Impact factor: 5.469

4.  Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S.

Authors:  T M Hackeng; S Yegneswaran; A E Johnson; J H Griffin
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

5.  Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.

Authors:  K M Seré; M P Janssen; G M Willems; G Tans; J Rosing; T M Hackeng
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

6.  Factor Va increases the affinity of factor Xa for prothrombin: a binding study using a novel photoactivable thiol-specific fluorescent probe.

Authors:  Subramanian Yegneswaran; José A Fernández; John H Griffin; Philip E Dawson
Journal:  Chem Biol       Date:  2002-04

7.  The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.

Authors:  E J Husten; C T Esmon; A E Johnson
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

8.  Equilibrium binding of nicotinamide nucleotides to lactate dehydrogenases.

Authors:  R A Stinson; J J Holbrook
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

9.  The use of ternary complexes to study ionizations and isomerizations during catalysis by lactate dehydrogenase.

Authors:  J J Holbrook; R A Stinson
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

10.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization.

Authors:  Rinku Majumder; Jianfang Wang; Barry R Lentz
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

View more
  6 in total

1.  The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Authors:  Matthew Ndonwi; Elodee A Tuley; George J Broze
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

2.  Bisaryl hydrazones as exchangeable biocompatible linkers.

Authors:  Anouk Dirksen; Subramanian Yegneswaran; Philip E Dawson
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-08       Impact factor: 15.336

3.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

4.  Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

Authors:  Mary J Heeb; Duane Prashun; John H Griffin; Bonno N Bouma
Journal:  FASEB J       Date:  2009-02-24       Impact factor: 5.191

Review 5.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

6.  Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.

Authors:  Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.